# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001599298-23-000012
Filing Date
2023-01-20
Accepted
2023-01-20 16:55:51
Documents
60
Period of Report
2023-01-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | smmt-20230116.htm iXBRL | 8-K | 54217
2 | EX-5.1 | exhibit51summittherapeut.htm | EX-5.1 | 1442
3 | EX-10.1 | exhibit101amendment1toak.htm | EX-10.1 | 10153
4 | EX-10.2 | redactedakeso-summitcomm.htm | EX-10.2 | 89494
5 | EX-10.3 | exhibit103promissorynote.htm | EX-10.3 | 37105
6 | EX-99.1 | a2023_prx0120xdealclosin.htm | EX-99.1 | 13417
11 |  | a2023_prx0120xdealclosin001.jpg | GRAPHIC | 239730
12 |  | a2023_prx0120xdealclosin002.jpg | GRAPHIC | 247498
13 |  | a2023_prx0120xdealclosin003.jpg | GRAPHIC | 300009
14 |  | a2023_prx0120xdealclosin004.jpg | GRAPHIC | 79042
15 |  | exhibit101amendment1toak001.jpg | GRAPHIC | 209133
16 |  | exhibit101amendment1toak002.jpg | GRAPHIC | 265369
17 |  | exhibit101amendment1toak003.jpg | GRAPHIC | 147734
18 |  | exhibit103promissorynote001.jpg | GRAPHIC | 260168
19 |  | exhibit103promissorynote002.jpg | GRAPHIC | 302236
20 |  | exhibit103promissorynote003.jpg | GRAPHIC | 286049
21 |  | exhibit103promissorynote004.jpg | GRAPHIC | 257682
22 |  | exhibit103promissorynote005.jpg | GRAPHIC | 202817
23 |  | exhibit103promissorynote006.jpg | GRAPHIC | 54391
24 |  | exhibit103promissorynote007.jpg | GRAPHIC | 259625
25 |  | exhibit103promissorynote008.jpg | GRAPHIC | 315505
26 |  | exhibit103promissorynote009.jpg | GRAPHIC | 286151
27 |  | exhibit103promissorynote010.jpg | GRAPHIC | 255798
28 |  | exhibit103promissorynote011.jpg | GRAPHIC | 202827
29 |  | exhibit103promissorynote012.jpg | GRAPHIC | 54413
30 |  | exhibit51summittherapeut001.jpg | GRAPHIC | 70075
31 |  | exhibit51summittherapeut002.jpg | GRAPHIC | 153343
32 |  | redactedakeso-summitcomm001.jpg | GRAPHIC | 225359
33 |  | redactedakeso-summitcomm002.jpg | GRAPHIC | 320999
34 |  | redactedakeso-summitcomm003.jpg | GRAPHIC | 317848
35 |  | redactedakeso-summitcomm004.jpg | GRAPHIC | 304021
36 |  | redactedakeso-summitcomm005.jpg | GRAPHIC | 323329
37 |  | redactedakeso-summitcomm006.jpg | GRAPHIC | 303920
38 |  | redactedakeso-summitcomm007.jpg | GRAPHIC | 339454
39 |  | redactedakeso-summitcomm008.jpg | GRAPHIC | 317939
40 |  | redactedakeso-summitcomm009.jpg | GRAPHIC | 299304
41 |  | redactedakeso-summitcomm010.jpg | GRAPHIC | 301141
42 |  | redactedakeso-summitcomm011.jpg | GRAPHIC | 301176
43 |  | redactedakeso-summitcomm012.jpg | GRAPHIC | 293868
44 |  | redactedakeso-summitcomm013.jpg | GRAPHIC | 294253
45 |  | redactedakeso-summitcomm014.jpg | GRAPHIC | 312879
46 |  | redactedakeso-summitcomm015.jpg | GRAPHIC | 239944
47 |  | redactedakeso-summitcomm016.jpg | GRAPHIC | 283197
48 |  | redactedakeso-summitcomm017.jpg | GRAPHIC | 201846
49 |  | redactedakeso-summitcomm018.jpg | GRAPHIC | 167463
50 |  | redactedakeso-summitcomm019.jpg | GRAPHIC | 53407
51 |  | redactedakeso-summitcomm020.jpg | GRAPHIC | 249774
52 |  | redactedakeso-summitcomm021.jpg | GRAPHIC | 260918
| Complete submission text file | 0001599298-23-000012.txt |  | 14435043

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | smmt-20230116.xsd | EX-101.SCH | 2159
8 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | smmt-20230116_def.xml | EX-101.DEF | 15316
9 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | smmt-20230116_lab.xml | EX-101.LAB | 29737
10 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | smmt-20230116_pre.xml | EX-101.PRE | 15973
54 | EXTRACTED XBRL INSTANCE DOCUMENT | smmt-20230116_htm.xml | XML | 11611

Mailing Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025
Business Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025 617-514-7149
Summit Therapeutics Inc. (Filer) CIK: 0001599298 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36866 | Film No.: 23541641
SIC: 2834 Pharmaceutical Preparations